Inventor · disambiguated record
Robert Fischer
Also filed as: FISCHER ROBERT · FISCHER ROBERT ANDREAS
7 granted patents·2 pending applications·8 citations·filing 2010–2022
76Inventor score
Files withOMEICOS THERAPEUTICS GMBH4MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN3LYSANDO AG1SCHUNCK WOLF-HAGEN1
Top patents by PatentIndex Score
9 records- 0174US9388400B2Composition for use in mycobacteria diagnosisLYSANDO AG·Filed 2013·Granted Jul 12, 2016·2 cites·16 claims
- 0271US9272991B2Eicosanoid derivativesSCHUNCK WOLF-HAGEN·Filed 2010·Granted Mar 1, 2016·4 cites·20 claims
- 0369US11365183B2Eicosanoid derivativesMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2019·Granted Jun 21, 2022·0 cites·13 claims
- 0468US10287262B2Eicosanoid derivativesMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2016·Granted May 14, 2019·1 cites·13 claims
- 0555US11096910B2Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac diseaseOMEICOS THERAPEUTICS GMBH·Filed 2016·Granted Aug 24, 2021·1 cites·19 claims
- 0650US12370158B2Analogs of CYP-eicosanoids for use in treating or preventing a disorder associated with neovascularization and/or inflammationOMEICOS THERAPEUTICS GMBH·Filed 2021·Granted Jul 29, 2025·0 cites·5 claims
- 0749US2025319054A1Synthetic Eicosanoid Analogues for the Treatment and Prevention of Diseases Associated with Increased GDF15 Plasma ConcentrationOMEICOS THERAPEUTICS GMBH·Filed 2022·Application pending·0 cites
- 0831US11130772B2CYP-eicosanoid derivativesMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2015·Granted Sep 28, 2021·0 cites·14 claims
- 0931US2019117597A1Analogs of cyp-eicosanoids for use in treating or preventing a disorder associated with neovascularization and/or inflammationOMEICOS THERAPEUTICS GMBH·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Fischer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →